ABSTRACT NUMBER: ESOC2026A1163 IMPACT OF INFLAMMATION ON CAROTID PLAQUE PROGRESSION AND RISK OF STROKE: INTERIM ANALYSIS OF THE INCREASE STUDY
Abstract Background and aims The benefit of carotid revascularization in patients with asymptomatic carotid stenosis (ACS) remains uncertain in the absence of additional plaque-vulnerability features. We hypothesized that plaque inflammation assessed by 18F-fluorodeoxyglucose positron-emission tomography (18FDG-PET) is associated with the risk of plaque progression and ipsilateral stroke during the follow-up. Methods Prospective study of adult patients with ACS ≥ 50%-99% in at least one internal carotid artery (diagnosed by carotid-ultrasound; graded and followed-up [at 1 and 2 years] by CT-angiography using NASCET criteria). Participants underwent carotid 18FDG-PET-CT ≤ 30 days after recruitment. The whole-vessel average of the standardized uptake value (WVa-SUV) of the proximal internal carotid artery was calculated and patients were followed-up for ≥1-year period. We studied the association between WVa-SUV and a composite outcome including plaque progression, defined as an increase of at least one category (moderate [50-69%], severe [70-99%], occlusion [100%]) or ipsilateral stroke/TIA. Logistic regression analyses were performed adjusting for baseline stenosis degree. Results We included 56 adult patients (73.2 ± 9.9 years, 23.7% women, median follow-up 21.7 months [IQR:15.2-27.3]) with 60 ACS (28.3% were 70-99%). Average WVa-SUV was 2.26 g/mL (IQR:1.96-2.56). Five (8.3%) ACS progressed and one (1.67%) patient had ipsilateral stroke. WVa-SUV was higher in these ACS (2.92 g/mL vs 2.23 g/mL, P = 0.005). In logistic regression analysis, WVa-SUV was associated with the risk of progression/stroke (aOR 1.47 per-0.1 g/mL-increase, 95%CI 1.09-1.99). Conclusions In patients with ACS, higher WVa-SUV was associated with plaque progression or ipsilateral stroke risk. The INCREASE study aims to confirm these results in a cohort of 102 patients. Conflict of interest Nothing to disclose.
Authors
- Natàlia Pérez de la Ossa (ORCID: https://orcid.org/0000-0002-6063-211X)
- Alejandro Fernández León (ORCID: https://orcid.org/0000-0002-1010-9451)
- Alejandro Martínez‐Domeño (ORCID: https://orcid.org/0000-0002-9933-3192)
- Anna Ramos‐Pachón (ORCID: https://orcid.org/0000-0002-7136-4245)
- Ana Aguilera‐Simón (ORCID: https://orcid.org/0000-0003-1428-8212)
- Luís Prats‐Sánchez (ORCID: https://orcid.org/0000-0002-3192-4631)
- Marc Delgado-Romeu
- Joan Miquel Fernandez Vidal
- Garbiñe Ezcurra
- Álvaro Lambea-Gil
- Marina Guasch-Jiménez
- Ariadna Margall Rodriguez
- Marta Gaspar Sardon
- Pol Camps-Renom
Institutions
- Hospital de Sant Pau (ES)
Publication Details
- Journal
- European Stroke Journal
- Published
- 2026-05-01
- DOI
- https://doi.org/10.1093/esj/aakag023.079
- Primary Topic
- Cerebrovascular and Carotid Artery Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00